{
  "id": "78b7f9ba80ed31ea",
  "title": "Pfizer BRAFTOVI Regimen Boosts Response Rates In BRAF V600E - Mutant Metastatic Colorectal Cancer",
  "description": "20260110T164500Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2026-01/67403042-pfizer-s-braftovi-regimen-boosts-response-rates-in-braf-v600e-mutant-metastatic-colorectal-cancer-020.htm",
  "published_at": "20260110T164500Z",
  "fetched_at": "2026-01-11T00:26:01.619835+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2026-01/67403042-pfizer-s-braftovi-regimen-boosts-response-rates-in-braf-v600e-mutant-metastatic-colorectal-cancer-020.htm",
    "url_mobile": "",
    "title": "Pfizer BRAFTOVI Regimen Boosts Response Rates In BRAF V600E - Mutant Metastatic Colorectal Cancer",
    "seendate": "20260110T164500Z",
    "socialimage": "https://www.finanznachrichten.de/chart-pfizer-inc-aktie-intraday-tradegate.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}